Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent
Sign Up to like & getrecommendations! Published in 2021 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2021.1932460
Abstract: ABSTRACT Introduction Hyperkalemia is a common finding in patients with advanced kidney disease for multiple reasons. Renin-Angiotensin-Aldosterone-System Inhibitors (RAASi) that are indicated for slowing down progression of kidney disease are often associated with hyperkalemia which… read more here.
Keywords: sodium zirconium; hyperkalemia; zirconium cyclosilicate; kidney disease ... See more keywords
Hyperkalaemia and potassium binders: Retrospective observational analysis looking at the efficacy and cost effectiveness of calcium polystyrene sulfonate and sodium zirconium cyclosilicate
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13766
Abstract: Hyperkalaemia is a common medical emergency in patients admitted to hospital. There is a limited evidence base supporting some of the commonly applied treatment strategies. Although, NICE has recommended the use of sodium zirconium cyclosilicate… read more here.
Keywords: calcium polystyrene; hyperkalaemia; zirconium cyclosilicate; sodium zirconium ... See more keywords
Comparison of Sodium Zirconium Cyclosilicate to Sodium Polystyrene Sulfonate in the Inpatient Management of Acute Hyperkalemia.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of pharmacy practice"
DOI: 10.1177/08971900231176462
Abstract: BACKGROUND Oral potassium binders have a role in the management of acute hyperkalemia among hospitalized patients. However, with therapeutic additions to this class, there is insufficient evidence between potassium binders to support a standard of… read more here.
Keywords: potassium; zirconium cyclosilicate; sodium; sodium zirconium ... See more keywords
Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1137981
Abstract: Hyperkalemia is a well-recognized electrolyte abnormality in patients with chronic kidney disease (CKD). Potassium binders are often used to prevent and treat hyperkalemia. However, few studies have evaluated the difference in serum potassium (K+) level-lowering… read more here.
Keywords: patients chronic; chronic kidney; hyperkalemia; sodium ... See more keywords